Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GELLIFY is an active Italian-headquartered global innovation platform focused on enabling digital transformation for traditional companies by connecting them with high-tech B2B startups. It provides venture capital investment—primarily at Series A—and guides portfolio companies through its proprietary "gellification" growth program. While it has made strategic acquisitions such as Bit2win from Accenture, there is no evidence that GELLIFY operates within the life sciences/biotech/pharma/healthcare sectors or develops therapeutic modalities. Its main activities are business consulting, startup acceleration, technology transfer, enterprise software expertise, and fostering corporate-startup collaboration across Europe and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GELLIFY.